1887
banner image
No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
oa
Hybrid optimal scheduling for intermittent androgen suppression of prostate cancer
Rent:
Rent this article for
Access full text Article
/content/aip/journal/chaos/20/4/10.1063/1.3526968
1.
1.P. Rennie, J. Read, and L. Murphy, in The Basic Science of Oncology, edited by I. F. Tannock, R. P. Hill, R. G. Bristow, and L. Harrington (McGraw-Hill, New York, 2005).
2.
2.K. Akakura, N. Bruchovsky, S. L. Goldenberg, P. S. Rennie, A. R. Buckley, and L. D. Sullivan, Cancer 71, 2782 (1993).
http://dx.doi.org/10.1002/1097-0142(19930501)71:9<2782::AID-CNCR2820710916>3.0.CO;2-Z
3.
3.L. Boccon-Gibod, P. Hammerrer, S. Madersbacher, N. Mottet, T. Prayer-Galetti, and U. Tunn, BJU Int. 100, 738 (2007).
http://dx.doi.org/10.1111/j.1464-410X.2007.07053.x
4.
4.N. Bruchovsky, L. Klotz, J. Crook, S. Malone, C. Ludgate, W. J. Morris, M. E. Geave, and S. L. Goldenberg, Cancer 107, 389 (2006).
http://dx.doi.org/10.1002/cncr.21989
5.
5.N. Bruchovsky, L. Klotz, J. Crook, and S. L. Goldenberg, Cancer 109, 858 (2007).
http://dx.doi.org/10.1002/cncr.22464
6.
6.A. De La Taille, M. Zerbib, S. Conquy, D. Amsellem-Ouazana, N. Thiounn, T. A. Flam, and B. Debre, BJU Int. 91, 18 (2003).
http://dx.doi.org/10.1046/j.1464-410X.2003.04015.x
7.
7.S. L. Goldenberg, N. Bruchovsky, M. E. Gleave, L. D. Sullivan, and K. Akakura, Urology 45, 839 (1995).
http://dx.doi.org/10.1016/S0090-4295(99)80092-2
8.
8.G. D. Grossfeld, U. B. Chaudhary, D. M. Reese, P. R. Carroll, and E. J. Small, Urology 58, 240 (2001).
http://dx.doi.org/10.1016/S0090-4295(01)01114-1
9.
9.S. Malone, G. Perry, L. Eapen, R. Segal, V. Gallant, S. Dahrouge, J. Crook, and J. N. Spaans, Int. J. Radiat. Oncol., Biol., Phys. 68, 699 (2007).
http://dx.doi.org/10.1016/j.ijrobp.2006.12.072
10.
10.M. Peyromaure, N. B. Delongchamps, B. Debre, and M. Zerbib, Urology 65, 724 (2005).
http://dx.doi.org/10.1016/j.urology.2004.11.002
11.
11.N. Sato, K. Akakura, S. Isaka, H. Nakatsu, M. Tanaka, H. Ito, and M. Masai, Urology 64, 341 (2004).
http://dx.doi.org/10.1016/j.urology.2004.03.032
12.
12.M. Scholz, R. Lam, S. Strum, R. Jennrich, H. Johnson, and T. Trilling, Urology 70, 506 (2007).
http://dx.doi.org/10.1016/j.urology.2007.04.015
13.
13.G. L. Shaw, P. Wilson, J. Cuzick, D. M. Prowse, S. L. Goldenberg, N. A. Spry, and T. Oliver, BJU Int. 99, 1056 (2007).
http://dx.doi.org/10.1111/j.1464-410X.2007.06770.x
14.
14.A. M. Ideta, G. Tanaka, T. Takeuchi, and K. Aihara, J. Nonlinear Sci. 18, 593 (2008).
http://dx.doi.org/10.1007/s00332-008-9031-0
15.
15.G. Tanaka, K. Tsumoto, S. Tsuji, and K. Aihara, Physica D 237, 2616 (2008).
http://dx.doi.org/10.1016/j.physd.2008.03.044
16.
16.T. Shimada and K. Aihara, Math. Biosci. 214, 134 (2008).
http://dx.doi.org/10.1016/j.mbs.2008.03.001
17.
17.Y. Hirata, N. Bruchovsky, and K. Aihara, J. Theor. Biol. 264, 517 (2010).
http://dx.doi.org/10.1016/j.jtbi.2010.02.027
18.
18.G. Tanaka, Y. Hirata, S. L. Goldenberg, N. Bruchovsky, and K. Aihara, Philos. Trans. R. Soc. London, Ser. A 368, 5029 (2010).
http://dx.doi.org/10.1098/rsta.2010.0221
19.
19.T. Suzuki, N. Bruchovsky, and K. Aihara, Philos. Trans. R. Soc. London, Ser. A 368, 5045 (2010).
http://dx.doi.org/10.1098/rsta.2010.0220
http://aip.metastore.ingenta.com/content/aip/journal/chaos/20/4/10.1063/1.3526968
Loading
/content/aip/journal/chaos/20/4/10.1063/1.3526968
Loading

Data & Media loading...

Loading

Article metrics loading...

/content/aip/journal/chaos/20/4/10.1063/1.3526968
2010-12-30
2014-08-23

Abstract

We propose a method for achieving an optimal protocol of intermittent androgen suppression for the treatment of prostate cancer. Since the model that reproduces the dynamical behavior of the surrogate tumor marker, prostate specific antigen, is piecewise linear, we can obtain an analytical solution for the model. Based on this, we derive conditions for either stopping or delaying recurrent disease. The solution also provides a design principle for the most favorable schedule of treatment that minimizes the rate of expansion of the malignant cell population.

Loading

Full text loading...

/deliver/fulltext/aip/journal/chaos/20/4/1.3526968.html;jsessionid=5wmurjihbyqm.x-aip-live-03?itemId=/content/aip/journal/chaos/20/4/10.1063/1.3526968&mimeType=html&fmt=ahah&containerItemId=content/aip/journal/chaos
true
true
This is a required field
Please enter a valid email address
This feature is disabled while Scitation upgrades its access control system.
This feature is disabled while Scitation upgrades its access control system.
752b84549af89a08dbdd7fdb8b9568b5 journal.articlezxybnytfddd
Scitation: Hybrid optimal scheduling for intermittent androgen suppression of prostate cancer
http://aip.metastore.ingenta.com/content/aip/journal/chaos/20/4/10.1063/1.3526968
10.1063/1.3526968
SEARCH_EXPAND_ITEM